annual CFF:
$930.61M+$709.29M(+320.49%)Summary
- As of today (June 20, 2025), CYTK annual cash flow from financing activities is $930.61 million, with the most recent change of +$709.29 million (+320.49%) on December 31, 2024.
- During the last 3 years, CYTK annual CFF has risen by +$610.63 million (+190.83%).
- CYTK annual CFF is now at all-time high.
Performance
CYTK Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$4.75M+$2.37M(+99.41%)Summary
- As of today (June 20, 2025), CYTK quarterly cash flow from financing activities is $4.75 million, with the most recent change of +$2.37 million (+99.41%) on March 1, 2025.
- Over the past year, CYTK quarterly CFF has dropped by -$99.04 million (-95.42%).
- CYTK quarterly CFF is now -99.42% below its all-time high of $821.01 million, reached on June 30, 2024.
Performance
CYTK quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$831.57M-$99.04M(-10.64%)Summary
- As of today (June 20, 2025), CYTK TTM cash flow from financing activities is $831.57 million, with the most recent change of -$99.04 million (-10.64%) on March 1, 2025.
- Over the past year, CYTK TTM CFF has increased by +$499.29 million (+150.26%).
- CYTK TTM CFF is now -27.55% below its all-time high of $1.15 billion, reached on June 30, 2024.
Performance
CYTK TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CYTK Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +320.5% | -95.4% | +150.3% |
| 3 y3 years | +190.8% | -94.9% | +99.2% |
| 5 y5 years | +482.4% | +10000.0% | +435.2% |
CYTK Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +320.5% | -99.4% | +166.2% | -27.6% | +909.2% |
| 5 y | 5-year | at high | +482.4% | -99.4% | +166.2% | -27.6% | +909.2% |
| alltime | all time | at high | >+9999.0% | -99.4% | +166.2% | -27.6% | >+9999.0% |
CYTK Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.75M(+99.4%) | $831.57M(-10.6%) |
| Dec 2024 | $930.61M(+320.5%) | $2.38M(-30.4%) | $930.61M(-15.2%) |
| Sep 2024 | - | $3.42M(-99.6%) | $1.10B(-4.4%) |
| Jun 2024 | - | $821.01M(+691.0%) | $1.15B(+245.4%) |
| Mar 2024 | - | $103.79M(-38.5%) | $332.29M(+50.1%) |
| Dec 2023 | $221.32M(-57.1%) | $168.80M(+211.3%) | $221.32M(+168.6%) |
| Sep 2023 | - | $54.22M(+890.3%) | $82.40M(-80.2%) |
| Jun 2023 | - | $5.47M(-176.3%) | $417.20M(+0.5%) |
| Mar 2023 | - | -$7.18M(-124.0%) | $415.14M(-19.6%) |
| Dec 2022 | $516.17M(+61.3%) | $29.89M(-92.3%) | $516.17M(+2.1%) |
| Sep 2022 | - | $389.02M(>+9900.0%) | $505.79M(+21.1%) |
| Jun 2022 | - | $3.42M(-96.4%) | $417.66M(+0.1%) |
| Mar 2022 | - | $93.85M(+381.1%) | $417.42M(+30.5%) |
| Dec 2021 | $319.98M(+36.7%) | $19.51M(-93.5%) | $319.98M(+5.2%) |
| Sep 2021 | - | $300.89M(+9377.0%) | $304.12M(+32.5%) |
| Jun 2021 | - | $3.17M(-188.3%) | $229.55M(-0.4%) |
| Mar 2021 | - | -$3.60M(-198.8%) | $230.54M(-1.5%) |
| Dec 2020 | $234.12M(+46.5%) | $3.64M(-98.4%) | $234.12M(-33.4%) |
| Sep 2020 | - | $226.33M(+5340.7%) | $351.60M(+156.4%) |
| Jun 2020 | - | $4.16M(<-9900.0%) | $137.13M(-11.7%) |
| Mar 2020 | - | -$11.00K(-100.0%) | $155.36M(-2.8%) |
| Dec 2019 | $159.79M(+1116.8%) | $121.12M(+921.3%) | $159.79M(+308.4%) |
| Sep 2019 | - | $11.86M(-47.0%) | $39.12M(+4.4%) |
| Jun 2019 | - | $22.40M(+407.2%) | $37.49M(+107.4%) |
| Mar 2019 | - | $4.42M(+879.2%) | $18.07M(+37.6%) |
| Dec 2018 | $13.13M(-94.2%) | $451.00K(-95.6%) | $13.13M(-11.7%) |
| Sep 2018 | - | $10.23M(+243.4%) | $14.88M(+144.6%) |
| Jun 2018 | - | $2.98M(-668.3%) | $6.08M(-94.5%) |
| Mar 2018 | - | -$524.00K(-123.9%) | $109.66M(-51.5%) |
| Dec 2017 | $225.92M(+1237.4%) | $2.19M(+53.0%) | $225.92M(+0.7%) |
| Sep 2017 | - | $1.43M(-98.7%) | $224.44M(+0.3%) |
| Jun 2017 | - | $106.56M(-7.9%) | $223.73M(+90.0%) |
| Mar 2017 | - | $115.73M(>+9900.0%) | $117.77M(+597.2%) |
| Dec 2016 | $16.89M(-29.4%) | $715.00K(-1.7%) | $16.89M(-57.6%) |
| Sep 2016 | - | $727.00K(+23.4%) | $39.82M(+1.4%) |
| Jun 2016 | - | $589.00K(-96.0%) | $39.26M(+1.4%) |
| Mar 2016 | - | $14.86M(-37.1%) | $38.71M(+61.9%) |
| Dec 2015 | $23.91M(-51.1%) | $23.64M(>+9900.0%) | $23.91M(+154.3%) |
| Sep 2015 | - | $164.00K(+300.0%) | $9.40M(+1.8%) |
| Jun 2015 | - | $41.00K(-36.9%) | $9.24M(+0.1%) |
| Mar 2015 | - | $65.00K(-99.3%) | $9.23M(-81.1%) |
| Dec 2014 | $48.95M | $9.13M(>+9900.0%) | $48.95M(+3.4%) |
| Sep 2014 | - | $0.00(-100.0%) | $47.33M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $35.00K(-99.9%) | $46.81M(-13.7%) |
| Mar 2014 | - | $39.78M(+429.3%) | $54.26M(+274.5%) |
| Dec 2013 | $14.49M(-75.2%) | $7.52M(-1556.6%) | $14.49M(+107.1%) |
| Sep 2013 | - | -$516.00K(-106.9%) | $7.00M(-1.5%) |
| Jun 2013 | - | $7.48M(>+9900.0%) | $7.10M(-87.2%) |
| Mar 2013 | - | $5000.00(-80.0%) | $55.66M(-4.6%) |
| Dec 2012 | $58.33M(+169.9%) | $25.00K(-106.1%) | $58.33M(-3.9%) |
| Sep 2012 | - | -$412.00K(-100.7%) | $60.70M(-0.4%) |
| Jun 2012 | - | $56.05M(+2001.5%) | $60.93M(+148.4%) |
| Mar 2012 | - | $2.67M(+11.4%) | $24.53M(+13.5%) |
| Dec 2011 | $21.61M(+748.9%) | $2.39M(-1437.4%) | $21.61M(-10.1%) |
| Sep 2011 | - | -$179.00K(-100.9%) | $24.03M(+0.8%) |
| Jun 2011 | - | $19.65M(-7867.2%) | $23.84M(-6631.5%) |
| Mar 2011 | - | -$253.00K(-105.3%) | -$365.00K(-114.3%) |
| Dec 2010 | $2.55M(-91.2%) | $4.81M(-1394.1%) | $2.55M(-199.9%) |
| Sep 2010 | - | -$372.00K(-91.8%) | -$2.55M(-40.4%) |
| Jun 2010 | - | -$4.55M(-271.3%) | -$4.28M(-133.5%) |
| Mar 2010 | - | $2.66M(-1045.9%) | $12.76M(-55.7%) |
| Dec 2009 | $28.81M(-934.7%) | -$281.00K(-86.6%) | $28.81M(+1.5%) |
| Sep 2009 | - | -$2.10M(-116.8%) | $28.39M(-3.7%) |
| Jun 2009 | - | $12.48M(-33.3%) | $29.49M(+81.3%) |
| Mar 2009 | - | $18.71M(-2795.5%) | $16.27M(-571.5%) |
| Dec 2008 | -$3.45M(-109.9%) | -$694.00K(-30.8%) | -$3.45M(+128.2%) |
| Sep 2008 | - | -$1.00M(+35.5%) | -$1.51M(-123.7%) |
| Jun 2008 | - | -$740.00K(-27.0%) | $6.39M(-4.7%) |
| Mar 2008 | - | -$1.01M(-181.4%) | $6.71M(-80.7%) |
| Dec 2007 | $34.72M(-60.0%) | $1.25M(-82.0%) | $34.72M(-50.4%) |
| Sep 2007 | - | $6.90M(-1719.7%) | $69.98M(-0.6%) |
| Jun 2007 | - | -$426.00K(-101.6%) | $70.39M(-9.1%) |
| Mar 2007 | - | $27.00M(-26.0%) | $77.40M(-10.7%) |
| Dec 2006 | $86.72M(+1492.4%) | $36.51M(+399.4%) | $86.72M(+54.6%) |
| Sep 2006 | - | $7.31M(+11.0%) | $56.10M(+14.4%) |
| Jun 2006 | - | $6.58M(-81.9%) | $49.05M(+16.0%) |
| Mar 2006 | - | $36.32M(+517.7%) | $42.27M(+676.2%) |
| Dec 2005 | $5.45M(-94.7%) | $5.88M(+2144.3%) | $5.45M(+579.9%) |
| Sep 2005 | - | $262.00K(-237.2%) | $801.00K(+2570.0%) |
| Jun 2005 | - | -$191.00K(-62.2%) | $30.00K(-100.0%) |
| Mar 2005 | - | -$505.00K(-140.9%) | $102.09M(-0.2%) |
| Dec 2004 | $102.32M(+154.3%) | $1.24M(-342.6%) | $102.32M(+1.2%) |
| Sep 2004 | - | -$509.00K(-100.5%) | $101.09M(-0.5%) |
| Jun 2004 | - | $101.87M(<-9900.0%) | $101.59M(<-9900.0%) |
| Mar 2004 | - | -$272.00K | -$272.00K |
| Dec 2003 | $40.24M(+726.4%) | - | - |
| Dec 2002 | $4.87M | - | - |
FAQ
- What is Cytokinetics Incorporated annual cash flow from financing activities?
- What is the all time high annual CFF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CFF year-on-year change?
- What is Cytokinetics Incorporated quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly CFF year-on-year change?
- What is Cytokinetics Incorporated TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM CFF year-on-year change?
What is Cytokinetics Incorporated annual cash flow from financing activities?
The current annual CFF of CYTK is $930.61M
What is the all time high annual CFF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual cash flow from financing activities is $930.61M
What is Cytokinetics Incorporated annual CFF year-on-year change?
Over the past year, CYTK annual cash flow from financing activities has changed by +$709.29M (+320.49%)
What is Cytokinetics Incorporated quarterly cash flow from financing activities?
The current quarterly CFF of CYTK is $4.75M
What is the all time high quarterly CFF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly cash flow from financing activities is $821.01M
What is Cytokinetics Incorporated quarterly CFF year-on-year change?
Over the past year, CYTK quarterly cash flow from financing activities has changed by -$99.04M (-95.42%)
What is Cytokinetics Incorporated TTM cash flow from financing activities?
The current TTM CFF of CYTK is $831.57M
What is the all time high TTM CFF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM cash flow from financing activities is $1.15B
What is Cytokinetics Incorporated TTM CFF year-on-year change?
Over the past year, CYTK TTM cash flow from financing activities has changed by +$499.29M (+150.26%)